EU extends authorization of mpox vaccine to adolescents
EU extends authorization of the mpox vaccine to adolescents
The European Commission on Friday extended the authorization of the Imvanex mpox vaccine to teenagers aged 12 to 17. "Although the overall risk of being infected with mpox for the general EU population remains low,
Bavarian says mpox vaccine approved by EU regulator for adolescents
Bavarian Nordic said on Thursday its mpox vaccine was approved by the EU's drug regulator for use in adolescents, bolstering the case for using the shot in the 12 to 17 age group to contain an outbreak in parts of Africa.
WHO authorizes mpox vaccine, which should ease global access
The World Health Organization announced Friday it has authorized the use of an mpox vaccine, calling it an “important step” in the fight against the disease.   The move could help national
Bavarian Gets EU Approval for Mpox Vaccine for Adolescents
Bavarian Nordic A/S, one of the only companies with a vaccine approved for mpox, has received regulatory approval in Europe for the use of its jab for adolescents.
Gavi to buy 500,000 mpox vaccine doses from Bavarian Nordic
The global vaccine group Gavi will buy 500,000 doses of Bavarian Nordic's mpox vaccine, its first purchase of the shot to help battle an outbreak in parts of Africa, the group said on Wednesday. In 2024,
Bavarian Nordic mpox shot gains approval for adolescents in EU
The European Commission has approved Bavarian Nordic's (OTCPK:BVNRY)(OTCPK:BVNKF) mpox shot for adolescents between 12 and 17 years old. Approval was based on data from a clinical study of more than 300 adolescents and 200 adults that found non-inferior immune responses and similar safety profile between both age groups after two standard doses
Global vaccine alliance GAVI to buy 500,000 doses of mpox vaccine
The global vaccine alliance Gavi says it will buy 500,000 doses of vaccine against mpox to fight outbreaks of the disease in ...
Medscape17h
EMA Broadens Imvanex Vaccine Use to Teens as Mpox Cases Rise
With more than 200 mpox-related deaths reported globally, the EMA has approved Imvanex for adolescents aged 12-17 years.
World better positioned against mpox than for COVID: vaccine alliance
Lessons learned from the COVID pandemic have left the world in a much better position to tackle the current mpox epidemic ...
Mpox Vaccine Update Issued by WHO
The announcement marks the first mpox vaccine to be added to the WHO's prequalification list to facilitate timely access and ...
Patients desperately wait for mpox vaccine at South Kivu Province clinic
Congo's South Kivu province is at the epicenter of the world’s latest mpox outbreak, in what the World Health Organization ...
DPA International on MSN2d
Half a million mpox vaccine doses for Africa ordered by Gavi alliance
The global vaccine group Gavi has ordered 500,000 mpox vaccine doses from the German-Danish company Bavarian Nordic. The UN ...
WHO clears Bavarian Nordic's vaccine for mpox, sets up access scheme
The World Health Organization and partners on Friday set up a scheme to help bring mpox vaccines, tests and treatments to the ...
Mpox: Three ongoing vaccine trials to watch
As the World Health Organization (WHO) has declared mpox an emergency, the Clinical Trials Arena team investigates ongoing ...